Savara Pharmaceuticals
SVRA
#6601
Rank
ยฃ0.43 B
Marketcap
ยฃ2.55
Share price
-1.54%
Change (1 day)
-32.30%
Change (1 year)

Earnings for Savara Pharmaceuticals (SVRA)

Earnings in 2024 (TTM): -ยฃ64.45 Million

According to Savara Pharmaceuticals's latest financial reports the company's current earnings are N/A. In 2023 the company made an earning of -ยฃ43.64 Million a decrease over its 2022 earnings that were of -ยฃ30.44 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Savara Pharmaceuticals from 2002 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -ยฃ64.45 Million47.69%
2023 -ยฃ43.64 Million43.38%
2022 -ยฃ30.44 Million-11.31%
2021 -ยฃ34.32 Million-13.3%
2020 -ยฃ39.59 Million-36.53%
2019 -ยฃ62.37 Million13.76%
2018 -ยฃ54.83 Million105.54%
2017 -ยฃ26.68 Million34.11%
2016 -ยฃ19.89 Million-37.43%
2015 -ยฃ31.79 Million38.81%
2014 -ยฃ22.9 Million33.62%
2013 -ยฃ17.14 Million38.49%
2012 -ยฃ12.38 Million24.59%
2011 -ยฃ9.94 Million-36.5%
2010 -ยฃ15.65 Million-3.14%
2009 -ยฃ16.15 Million-23.28%
2008 -ยฃ21.05 Million8.52%
2007 -ยฃ19.4 Million-34.14%
2006 -ยฃ29.46 Million184.43%
2005 -ยฃ10.36 Million90.75%
2004 -ยฃ5.43 Million190.35%
2003 -ยฃ1.87 Million11.64%
2002 -ยฃ1.68 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-ยฃ14.49 Million-78.11%๐Ÿ‡บ๐Ÿ‡ธ USA
-ยฃ94.02 Million 42.09%๐Ÿ‡บ๐Ÿ‡ธ USA